ArticleOncology letters2019

The efficacy and safety of bevacizumab in addition to platinum-based chemotherapy for the first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer: Final results of AVALANCHE, an observational cohort study.

Edina Tolnay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.